MediTrust Health, a Shanghai-based online healthcare payment and pharmacy platform, secured RMB 2 billion ($300) in Series C as the company plans for an IPO by the end of this year. Boyu Capital, Lillly Asia Ventures, and CICC participated in the round. The funding round came five months after the company raised RMB 1 billion in Series B, in which Ant Group and Sinovation Ventures participated. [KrAsia]